Skip to main content
Top
Published in: Clinical Oral Investigations 11/2019

01-11-2019 | Nifedipine | Original Article

Relationship between periodontal inflammation and calcium channel blockers induced gingival overgrowth—a cross-sectional study in a Japanese population

Authors: Shinji Matsuda, Ai Okanobu, Saki Hatano, Mikihito Kajiya, Shinya Sasaki, Yuta Hamamoto, Tomoyuki Iwata, Kazuhisa Ouhara, Katsuhiro Takeda, Noriyoshi Mizuno, Tsuyoshi Fujita, Hidemi Kurihara

Published in: Clinical Oral Investigations | Issue 11/2019

Login to get access

Abstract

Objectives

Periodontal inflammation is regarded as a risk factor for drug-induced gingival overgrowth (DIGO). In order to elucidate the involvement of periodontal inflammation in DIGO, the periodontal status of subjects who do not develop DIGO despite receiving causative drugs (non-responders) needs to be examined. Therefore, the aim of the present study which was a pilot study was to assess periodontal inflammatory variables in responders (calcium channel blocker induced-GO patients), non-responders, and patients who did not receive causative drugs (non-consumers).

Materials and methods

The following parameters were measured: (1) existence of gingival overgrowth, (2) number of teeth, (3) mean periodontal pocket depth (PPD), and (4) percentage of positive sites for bleeding on probing (BOP). The periodontal inflamed surface area (PISA) and periodontal epithelial surface area (PESA) and the PISA/PESA ratio which indicated the degree of periodontal inflammation in each patient were also used to evaluate periodontal inflammation.

Results

Thirteen responders, 32 non-responders, and 83 non-consumers were included in the analyses. The mean PPD, percentage of BOP, PESA, and PISA, and the PISA/PESA ratio were significantly higher in responders than in non-responders and non-consumers (p < 0.01). The BOP, PISA, and PISA/PESA ratio were significantly lower in non-responders than in non-consumers (p < 0.05). A positive correlation was found between PPD and age in non-consumers. On the other hand, a negative correlation was noted between PPD and age in non-responders.

Conclusions

Periodontal inflammation may be associated with the initiation of DIGO.

Clinical relevance

It could be speculated that periodontal therapy before the administration of calcium channel blockers may prevent the development of gingival overgrowth.
Literature
1.
go back to reference Trackman PC, Kantarci A (2004) Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 15(3):165–175CrossRef Trackman PC, Kantarci A (2004) Connective tissue metabolism and gingival overgrowth. Crit Rev Oral Biol Med 15(3):165–175CrossRef
7.
go back to reference Seymour RA, Ellis JS, Thomason JM (2000) Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 27(4):217–223CrossRef Seymour RA, Ellis JS, Thomason JM (2000) Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 27(4):217–223CrossRef
10.
go back to reference Brunet L, Miranda J, Roset P, Berini L, Farre M, Mendieta C (2001) Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Investig 31(9):781–788CrossRef Brunet L, Miranda J, Roset P, Berini L, Farre M, Mendieta C (2001) Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Investig 31(9):781–788CrossRef
13.
go back to reference Bullon P, Machuca G, Martinez-Sahuquillo A, Rios JV, Rojas J, Lacalle JR (1994) Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Periodontol 21(4):256–259CrossRef Bullon P, Machuca G, Martinez-Sahuquillo A, Rios JV, Rojas J, Lacalle JR (1994) Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Periodontol 21(4):256–259CrossRef
14.
go back to reference Bullon P, Machuca G, Martinez Sahuquillo A, Rojas J, Lacalle JR, Rios JV, Velasco E (1995) Clinical assessment of gingival size among patients treated with diltiazem. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(3):300–304CrossRef Bullon P, Machuca G, Martinez Sahuquillo A, Rojas J, Lacalle JR, Rios JV, Velasco E (1995) Clinical assessment of gingival size among patients treated with diltiazem. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(3):300–304CrossRef
15.
go back to reference Neumann C, Willershausen-Zonnchen B, Klug C, Darius H (1996) Clinical assessment of periodontal conditions in patients treated with nifedipine. Eur J Med Res 1(6):273–279PubMed Neumann C, Willershausen-Zonnchen B, Klug C, Darius H (1996) Clinical assessment of periodontal conditions in patients treated with nifedipine. Eur J Med Res 1(6):273–279PubMed
17.
go back to reference Thomason JM, Seymour RA, Rice N (1993) The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 20(1):37–40CrossRef Thomason JM, Seymour RA, Rice N (1993) The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 20(1):37–40CrossRef
21.
go back to reference Angelopoulos AP, Goaz PW (1972) Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 34(6):898–906CrossRef Angelopoulos AP, Goaz PW (1972) Incidence of diphenylhydantoin gingival hyperplasia. Oral Surg Oral Med Oral Pathol 34(6):898–906CrossRef
24.
go back to reference Hassell T, O'Donnell J, Pearlman J, Tesini D, Murphy T, Best H (1984) Phenytoin induced gingival overgrowth in institutionalized epileptics. J Clin Periodontol 11(4):242–253CrossRef Hassell T, O'Donnell J, Pearlman J, Tesini D, Murphy T, Best H (1984) Phenytoin induced gingival overgrowth in institutionalized epileptics. J Clin Periodontol 11(4):242–253CrossRef
Metadata
Title
Relationship between periodontal inflammation and calcium channel blockers induced gingival overgrowth—a cross-sectional study in a Japanese population
Authors
Shinji Matsuda
Ai Okanobu
Saki Hatano
Mikihito Kajiya
Shinya Sasaki
Yuta Hamamoto
Tomoyuki Iwata
Kazuhisa Ouhara
Katsuhiro Takeda
Noriyoshi Mizuno
Tsuyoshi Fujita
Hidemi Kurihara
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 11/2019
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-019-02846-8

Other articles of this Issue 11/2019

Clinical Oral Investigations 11/2019 Go to the issue